Differentiation between normal renal tissue and renal cell carcinoma using optical coherence tomography (OCT): a prospective human in-vivo study.

Differentiation between normal renal tissue and renal cell carcinoma using optical coherence tomography (OCT): a prospective human in-vivo study. - Differentiating renal tumors using in-vivo OCT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34505

Enrollment

Registered

2010-09-23

Start date

2010-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cell cancer renal mass

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: > 18 yrs solid, enhancing renal mass, suspect for malignancy scheduled for (open or laparoscopic) nephrectomy or partial nephrectomy signed informed consent

Exclusion criteria

Exclusion criteria: cystic renal mass

Design outcomes

Primary

Measure	Time frame
Primary study outcome is the attenuation-coefficient measured by OCT of the 2 tissue types: normal renal parenchyma and malignant (RCC) tissue.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results